Keenan Greg

Track

Insider profile

Keenan Greg's trades of Aurinia Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
344.41
Quantity 80,143
Value US$130,793
Transaction date
Proposed sale
Price
97.61
Quantity 95,981
Value US$1,213,272
Transaction date
Proposed sale
Price
433.14
Quantity 46,438
Value US$3,365,811
Transaction date
Proposed sale
Price
2,164.00
Quantity 25,000
Value US$54,100,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-05
PrS Proposed sale
80,143
344.41
US$130,793 		80,143 344.41 US$130,793
2026-06-05 2026-06-05
PrS Proposed sale
95,981
97.61
US$1,213,272 		95,981 97.61 US$1,213,272
2026-06-04 2026-06-04
PrS Proposed sale
46,438
433.14
US$3,365,811 		46,438 433.14 US$3,365,811
2026-06-02 2026-06-02
PrS Proposed sale
25,000
2,164.00
US$54,100,000 		25,000 2,164.00 US$54,100,000
2025-08-05 2025-08-01
S Sale
20,000 -13.0%
10.50
US$210,000 		20,000 -13.0% 10.50 US$210,000
2025-03-07 2025-03-07
S Sale
8,305 -5.1%
8.23
US$68,350 		8,305 -5.1% 8.23 US$68,350
2025-03-04 2025-03-03
S Sale
12,239 -7.0%
8.00
US$97,912 		12,239 -7.0% 8.00 US$97,912